Tuesday, August 23, 2016 8:08:14 AM
From the 10Q yesterday LMAO:
7. Common Stock
During the three months ended March 31, 2016, the Company's board of directors authorized the issuance of 5,000 shares of its common stock to each of its seven (7) board of directors for their service through March 31, 2016. The Company recorded $31,388 in board of director fees on its statement of operations for the three months ended March 31, 2016.
During the three months ended March 31, 2016, the Company's board of directors authorized the issuance of shares of its common stock to a consultant for their service through March 31, 2016. The Company recorded $29,040 in consulting fees on its statement of operations for the three months ended March 31, 2016. As of March 31, 2016 the stock was yet to be issued. During the three months ended June 30, 2016 the Company's board of directors authorized the issuance of 50,000 shares of its common stock to a consultant for their services for the prior three months and the three months through June 30, 2016. The Company recorded $51,960 in consulting fees on its statement of operations for the three months ended June 30, 2016.
During the three months ended March 31, 2016, the Company's board of directors authorized the issuance of 87,500 shares of its common stock to two (2) board of directors and two (2) consultants for their service through March 31, 2016. The Company recorded $78,470 in professional fees on its statement of operations for the three months ended March 31, 2016. As of March 31, 2016, the stock has yet to be issued.
During the three months ended March 31, 2016, the Company's board of directors authorized the issuance of 30,000 shares to a consultant for services to be provided during through March 31, 2016. The value of the issuance was determined to be $40,726.
During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 5,000 shares of its common stock to each of its seven (7) board of directors for their service through June 30, 2016. The Company recorded $80,612 in board of director fees on its statement of operations for the three months ended June 30, 2016.
During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 72,115 shares of its common stock to five (5) consultants of which three (3) are also members of the board of directors. The stock was issued for their services through June 30, 2016. The value of the issuance was determined to be $75,000.
During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 19,457 shares to a consultant for services that were provided during through June 30, 2016. The value of the issuance was determined to be $21,500.
During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 25,000 shares to a consultant for services that were provided during through June 30, 2016. The value of the issuance was determined to be $40,000.
During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 50,000 shares to two (2) consultants for services that were provided during through June 30, 2016. The value of the issuance was determined to be $160,000.
During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 30,000 shares in payment for a liability owed on the Company's joint venture agreement. The value of the issuance was determined to be $35,000.
During the three months ended June 30, 2016, the Company's received 256,448 shares of their common stock as was required in their legal settlement. The value of the return was valued to be $479,558 and was offset against prior professional fees incurred.
During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 238,768 shares in payment for a liabilities owed by the Company in the amount of $220,833.
During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 400,000 shares of its common stock to five (5) consultants of which three (3) are also members of the board of directors. The stock was issued for their services through June 30, 2016. The value of the issuance was determined to be $630,500.
During the three months ended June 30, 2016, the Company's board of directors authorized the issuance of 150,000 shares to a consultant, who is also on the board of directors, for services that were provided during through June 30, 2016. The value of the issuance was determined to be $116,500. 100,000 shares are payable in the future.
I hope you all go to jail!! SCAMMERS!!
Recent CBDS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:58:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:34:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 07:44:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 07:24:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 06:46:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 06:39:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 06:22:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 05:09:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/07/2024 08:05:49 PM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 02/06/2024 08:19:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/01/2024 12:01:39 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 08:08:10 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 04:21:57 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 09/05/2023 07:09:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 04:03:07 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM